Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cabaletta Bio, Inc. (CABA) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cabaletta Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1759138.
Total stock buying since 2019: $13,043,785.
Total stock sales since 2019: $21,035,841.
Total stock option exercises since 2019: $161,600.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 11,000 | $219,241 | 11,000 | $11,110 |
| 2023 | 0 | $0 | 99,000 | $1,492,600 | 99,000 | $99,990 |
| 2022 | 346,000 | $343,790 | 0 | $0 | 50,000 | $50,500 |
| 2021 | 0 | $0 | 1,307,000 | $14,928,500 | 0 | $0 |
| 2020 | 0 | $0 | 298,000 | $4,395,500 | 0 | $0 |
| 2019 | 1,154,545 | $12,699,995 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 0 | $0 | 11,000 | $219,241 | 11,000 | $11,110 |
| 2023-12 | 0 | $0 | 11,000 | $241,879 | 11,000 | $11,110 |
| 2023-11 | 0 | $0 | 11,000 | $194,787 | 11,000 | $11,110 |
| 2023-10 | 0 | $0 | 11,000 | $151,789 | 11,000 | $11,110 |
| 2023-09 | 0 | $0 | 11,000 | $198,011 | 11,000 | $11,110 |
| 2023-08 | 0 | $0 | 11,000 | $149,754 | 11,000 | $11,110 |
| 2023-07 | 0 | $0 | 11,000 | $153,615 | 11,000 | $11,110 |
| 2023-06 | 0 | $0 | 11,000 | $142,923 | 11,000 | $11,110 |
| 2023-05 | 0 | $0 | 22,000 | $259,842 | 22,000 | $22,220 |
| 2022-10 | 346,000 | $343,790 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 50,000 | $50,500 |
| 2021-11 | 0 | $0 | 295,000 | $3,835,000 | 0 | $0 |
| 2021-09 | 0 | $0 | 625,000 | $6,062,500 | 0 | $0 |
| 2021-01 | 0 | $0 | 387,000 | $5,031,000 | 0 | $0 |
| 2020-12 | 0 | $0 | 298,000 | $4,395,500 | 0 | $0 |
| 2019-10 | 1,154,545 | $12,699,995 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-19 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 19.93 | 219,241 |
| 2024-01-19 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-12-19 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 21.99 | 241,879 |
| 2023-12-19 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-11-20 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 17.71 | 194,787 |
| 2023-11-20 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-10-19 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 13.80 | 151,789 |
| 2023-10-19 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-09-19 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 18.00 | 198,011 |
| 2023-09-19 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-08-21 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 13.61 | 149,754 |
| 2023-08-21 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-07-19 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 13.96 | 153,615 |
| 2023-07-19 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-06-20 | Binder Gwendolyn (See Remarks) | Sale | 11,000 | 12.99 | 142,923 |
| 2023-06-20 | Binder Gwendolyn (See Remarks) | Option Ex | 11,000 | 1.01 | 11,110 |
| 2023-05-19 | Binder Gwendolyn (See Remarks) | Sale | 22,000 | 11.81 | 259,842 |
| 2023-05-19 | Binder Gwendolyn (See Remarks) | Option Ex | 22,000 | 1.01 | 22,220 |
| 2022-10-19 | Nichtberger Steven (President & CEO) | Buy | 8,127 | 1.25 | 10,150 |
| 2022-10-18 | Binder Gwendolyn (See Remarks) | Buy | 20,000 | .99 | 19,900 |
| 2022-10-18 | Bollard Catherine (Director) | Buy | 1,000 | .99 | 994 |
| 2022-10-18 | Marda Anup (Chief Financial Officer) | Buy | 50,000 | .99 | 49,600 |
| 2022-10-18 | Nichtberger Steven (President & CEO) | Buy | 141,873 | .99 | 141,021 |
| 2022-10-18 | Simon Mark (Director) | Buy | 125,000 | .98 | 122,125 |
| 2022-01-31 | Nichtberger Steven (President & CEO) | Option Ex | 50,000 | 1.01 | 50,500 |
| 2021-11-01 | Schwab Andrew J. (10% Owner) | Sale | 295,000 | 13.00 | 3,835,000 |
| 2021-09-07 | Schwab Andrew J. (10% Owner) | Sale | 625,000 | 9.70 | 6,062,500 |
| 2021-01-12 | Schwab Andrew J. (10% Owner) | Sale | 85,000 | 13.00 | 1,105,000 |
| 2021-01-08 | Schwab Andrew J. (10% Owner) | Sale | 302,000 | 13.00 | 3,926,000 |
| 2020-12-10 | Schwab Andrew J. (10% Owner) | Sale | 298,000 | 14.75 | 4,395,500 |
| 2019-10-29 | Schwab Andrew J. (10% Owner) | Buy | 454,545 | 11.00 | 4,999,995 |
| 2019-10-29 | Deerfield Partners, L.p. | Buy | 700,000 | 11.00 | 7,700,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CABA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cabaletta Bio, Inc. (symbol CABA, CIK number 1759138) see the Securities and Exchange Commission (SEC) website.